These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33306763)

  • 1. A rare case of multiple primary extragastrointestinal stromal tumors in the abdominopelvic cavity detected by
    Xiao JX; Ye J; Huang SS; Guo CM; Su M; Wang D
    Hell J Nucl Med; 2020; 23(3):346-348. PubMed ID: 33306763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal Stromal Tumor of the Prostate: Staging and Evaluation of Response to Therapy With 18F-FDG PET/CT.
    Alabed YZ
    Clin Nucl Med; 2018 Jan; 43(1):52-54. PubMed ID: 29166334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study.
    Goldstein D; Tan BS; Rossleigh M; Haindl W; Walker B; Dixon J
    Oncology; 2005; 69(4):326-32. PubMed ID: 16293972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An invasive extragastrointestinal stromal tumor curably resected following imatinib treatment.
    Muto M; Fujiya M; Okada T; Inoue M; Yabuki H; Kohgo Y
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):329-32. PubMed ID: 24078991
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Altini C; Mammucci P; Pisani AR; D'Alò C; Sardaro A; Rubini D; Ferrari C; Rubini G
    Hell J Nucl Med; 2021; 24(3):239-246. PubMed ID: 34901964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.
    Choi H; Charnsangavej C; Faria SC; Macapinlac HA; Burgess MA; Patel SR; Chen LL; Podoloff DA; Benjamin RS
    J Clin Oncol; 2007 May; 25(13):1753-9. PubMed ID: 17470865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla JF; Sainz-Esteban A; Barragán J; Portilla-Quattrociocchi H; Carril JM
    Rev Esp Med Nucl; 2008; 27(3):168-75. PubMed ID: 18570858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of early response to imatinib 800 mg after 400 mg progression by ¹⁸F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors.
    Chacón M; Eleta M; Espindola AR; Roca E; Méndez G; Rojo S; Pupareli C
    Future Oncol; 2015; 11(6):953-64. PubMed ID: 25760976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to
    Van Weehaeghe D; Gheysens O; Vandecaveye V; Schöffski P; Van Laere K; Deroose CM
    BMC Cancer; 2018 Mar; 18(1):253. PubMed ID: 29506493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of extension of gastrointestinal stromal tumors (GIST) treated with imatinib (Gleevec®) by 18F-FDG PET/CT.
    Valls-Ferrusola E; García-Garzón JR; Ponce-López A; Soler-Peter M; Fuertes-Cabero S; Moragas-Solanes M; Riera-Gil E; Carrió-Gasset I; Lomeña-Caballero F
    Rev Esp Enferm Dig; 2012 Jul; 104(7):360-6. PubMed ID: 22849497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Images of a case of Carney triad by combined F-18 FDG PET/CT.
    Kato K; Koike W; Iwano S; Usami N; Yokoi K; Ueda Y; Naganawa S
    Clin Nucl Med; 2011 Aug; 36(8):698-700. PubMed ID: 21716025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Hepatic Gastrointestinal Stromal Tumor on 18 F-FDG PET/CT Images.
    Jiang Y; Lu Q; Lou C; Huang Z
    Clin Nucl Med; 2023 Aug; 48(8):722-724. PubMed ID: 37220247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early response to treatment with Glivec detected with 18F-FDG PET in a patient with gastrointestinal stromal tumor].
    Delgado Bolton RC; Ortega Candil A; Pérez Castejón MJ; Garcerant M; Cabrera Martín MN; Lapeña Gutiérrez L; Carreras Delgado JL
    Rev Esp Med Nucl; 2008; 27(2):112-7. PubMed ID: 18367049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response Assessment of Recurrent Extragastrointestinal Stromal Tumor of the Urinary Bladder to Imatinib: Findings on Serial
    Tripathy S; Arun Raj ST; Prakash S; Thanaignathan T; Shamim SA
    Indian J Nucl Med; 2020; 35(4):350-352. PubMed ID: 33642766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between FDG uptake and the pathological risk category in gastrointestinal stromal tumors.
    Otomi Y; Otsuka H; Morita N; Terazawa K; Furutani K; Harada M; Nishitani H
    J Med Invest; 2010 Aug; 57(3-4):270-4. PubMed ID: 20847527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Extragastrointestinal Stromal Tumor on FDG PET/CT.
    Zhang Y; Zhang A; Song L; Li X; Zhang W
    Clin Nucl Med; 2018 Sep; 43(9):705-706. PubMed ID: 30036257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral primary renal lymphoma in a pediatric patient: staging and response evaluation with ¹⁸F-FDG PET/CT.
    Dhull VS; Mukherjee A; Karunanithi S; Durgapal P; Bal C; Kumar R
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):49-52. PubMed ID: 25065972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
    Gayed I; Vu T; Iyer R; Johnson M; Macapinlac H; Swanston N; Podoloff D
    J Nucl Med; 2004 Jan; 45(1):17-21. PubMed ID: 14734662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary extragastrointestinal stromal tumor of the prostate: a case report.
    Zhou J; Teng X
    Anal Quant Cytopathol Histpathol; 2014 Feb; 36(1):55-60. PubMed ID: 24902373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07).
    Montemurro M; Cioffi A; Dômont J; Rutkowski P; Roth AD; von Moos R; Inauen R; Toulmonde M; Burkhard RO; Knuesli C; Bauer S; Cassier P; Schwarb H; Le Cesne A; Koeberle D; Bärtschi D; Dietrich D; Biaggi C; Prior J; Leyvraz S
    Cancer; 2018 Apr; 124(7):1449-1454. PubMed ID: 29315500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.